Twenty percent of patients experiencing a side effect related to bone marrow suppression and leukopenia have a TPMT mutation.61 Screening the UC population before initiation of thiopurine therapy may be advantageous. The gene discussed is TPMT; the disease is Decreased total leukocyte count.